Log in to save to my catalogue

Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds

Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ca41efae37a14af5b665d8b05d9bd17a

Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds

About this item

Full title

Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds

Publisher

Switzerland: MDPI AG

Journal title

Metabolites, 2022-12, Vol.12 (12), p.1210

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Cytotoxicity of de novo purine synthesis (DNPS) metabolites is critical to the pathogenesis of three known and one putative autosomal recessive disorder affecting DNPS. These rare disorders are caused by biallelic mutations in the DNPS genes phosphoribosylformylglycineamidine synthase (PFAS), phosphoribosylaminoimidazolecarboxylase/phosphoribosylam...

Alternative Titles

Full title

Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ca41efae37a14af5b665d8b05d9bd17a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ca41efae37a14af5b665d8b05d9bd17a

Other Identifiers

ISSN

2218-1989

E-ISSN

2218-1989

DOI

10.3390/metabo12121210

How to access this item